There is also evidence that the absence of EGFR amplification, TERT promoter mutation, and + 7/− 10 is associated with a better clinical course in tumors that qualify as IDH-wildtype glioblastoma by histologic features alone [38]. Here, EGFR is linked to glioblastoma.